Practical info & communications

The recently published OZAVIE observational study confirms that the combination of ceftazidime and avibactam (CAZ-AVI) is effective, with a clinical success rate ranging from 63.4% to 79% in the treatment of multidrug-resistant Gram-negative (MDR-GNB) infections. These rates increase from 65.6% ...

On 5 March, the WHO published a document entitled ‘The case for investment and action in infection prevention and control’. This document provides data on the expected return on investment and gu ...

The World Health Organisation (WHO) has published a global research agenda on antimicrobial resistance in human health, aimed at generating evidence to combat AMR in human health by 2030. This programme identifies 33 research priorities on bacterial and fungal infections, as well as seven priori ...

We are pleased to announce the launch of the call for projects for the targeted project COHORTES-MICROBIOMES, funded by the France 2030 Food Systems, Microbiomes and Health research programme (PEPR SAMS).

Discover the previous sessions of the ‘AMR Controversies’ conferences organised by DOSA (Observatoire numérique en sciences sociales de l'antibiorésistance) with Université Paris-Dauphine PSL, INRAE, SciencesPo and TélécomParis :

Register

The IReSP is launching the new e ...